Miro Venturi
Advisory Board Member at LongeVC
About
Miro Venturi is an Advisory Board member at LongeVC with a background in the pharmaceutical sector. He began in the pharmaceutical industry in 2002 as a Biomarker Laboratory Head at Pharmacia Corp (later Pfizer) in oncology R&D, later serving as Divisional Head in Biomarker Development at Novartis and holding senior biomarker and diagnostics roles at Roche, including Global Head of Diagnostics Biomarkers. He holds a Master's in Biochemistry from the Università di Bologna, a PhD in Biochemistry–Molecular Biophysics from Goethe University, and completed postdoctoral work at the National Institutes of Health.
Invests in
BiotechHealthtechLongevity
Investments
Board seats
Sintetica SA - Innovating Therapies
Per the firm's website.
Colleagues at LongeVC
Alex Zhavoronkov
Venture Partner at LongeVC
Artem Trotsyuk
Operating Partner - US at LongeVC
Artemy Shumskiy
Principal at LongeVC
Christine Yuan Huang
Advisory Board at LongeVC
Dr. Weigao Wang
Venture Fellow at LongeVC
Evelyne Bischof
Venture Partner at LongeVC
Evgeny Izumchenko
Venture Partner at LongeVC
Garri Zmudze
Managing Partner at LongeVC